Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Serum antibody responses of weanling mice and two-year-old children to pneumococcal-type 6A-protein conjugate vaccines of differing saccharide chain lengths.

Pichichero ME, Porcelli S, Treanor J, Anderson P.

Vaccine. 1998 Jan;16(1):83-91.

PMID:
9607014
[PubMed - indexed for MEDLINE]
2.
3.

Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide--protein conjugate vaccine is decreased by admixture of high doses of free saccharide.

Peeters CC, Tenbergen-Meekes AM, Poolman JT, Zegers BJ, Rijkers GT.

Vaccine. 1992;10(12):833-40.

PMID:
1455909
[PubMed - indexed for MEDLINE]
4.

Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.

de Velasco EA, Merkus D, Anderton S, Verheul AF, Lizzio EF, Van der Zee R, Van Eden W, Hoffman T, Verhoef J, Snippe H.

Infect Immun. 1995 Mar;63(3):961-8.

PMID:
7532630
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate.

Lu CH, Lee CJ, Kind P.

Infect Immun. 1994 Jul;62(7):2754-60.

PMID:
8005665
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.

Väkeväinen M, Eklund C, Eskola J, Käyhty H.

J Infect Dis. 2001 Sep 15;184(6):789-93. Epub 2001 Aug 14.

PMID:
11517443
[PubMed - indexed for MEDLINE]
Free Article
7.

Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.

Saeland E, Jakobsen H, Ingolfsdottir G, Sigurdardottir ST, Jonsdottir I.

J Infect Dis. 2001 Jan 15;183(2):253-260. Epub 2000 Dec 8.

PMID:
11110649
[PubMed - indexed for MEDLINE]
Free Article
8.

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.

Anttila M, Eskola J, Ahman H, Käyhty H.

Vaccine. 1999 Apr 9;17(15-16):1970-7.

PMID:
10217596
[PubMed - indexed for MEDLINE]
9.

Studies on vaccine control and immunogenicity of polysaccharides of Streptococcus pneumoniae.

Lee CJ, Lin KT.

Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S51-60. Review.

PMID:
6169130
[PubMed - indexed for MEDLINE]
10.

Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.

Kuo J, Douglas M, Ree HK, Lindberg AA.

Infect Immun. 1995 Jul;63(7):2706-13.

PMID:
7790088
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.

Nieminen T, Käyhty H, Leroy O, Eskola J.

Pediatr Infect Dis J. 1999 Sep;18(9):764-72.

PMID:
10493335
[PubMed - indexed for MEDLINE]
12.

Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides.

Robbins JB, Lee CJ, Rastogi SC, Schiffman G, Henrichsen J.

Infect Immun. 1979 Dec;26(3):1116-22.

PMID:
43290
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Non-interference between two protein carriers when used with the same polysaccharide for pneumococcal conjugate vaccines in 2-year-old children.

Anderson P, Treanor J, Porcelli S, Pichichero M.

Vaccine. 2003 Mar 28;21(13-14):1554-9.

PMID:
12615453
[PubMed - indexed for MEDLINE]
14.

Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.

Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier FC 3rd, Sacerdote DM, Bradford N, Moore C.

Pediatr Infect Dis J. 1998 Aug;17(8):685-91.

PMID:
9726341
[PubMed - indexed for MEDLINE]
15.

Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.

Korkeila M, Lehtonen H, Ahman H, Leroy O, Eskola J, Käyhty H.

Vaccine. 2000 Jan 18;18(13):1218-26.

PMID:
10649623
[PubMed - indexed for MEDLINE]
16.

Protective immunity of pneumococcal glycoconjugates.

Lee CJ, Lee LH, Frasch CE.

Crit Rev Microbiol. 2003;29(4):333-49. Review.

PMID:
14636043
[PubMed - indexed for MEDLINE]
17.

IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.

Soininen A, Seppälä I, Nieminen T, Eskola J, Käyhty H.

Vaccine. 1999 Apr 9;17(15-16):1889-97.

PMID:
10217586
[PubMed - indexed for MEDLINE]
18.

A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice.

Peeters CC, Tenbergen-Meekes AM, Evenberg DE, Poolman JT, Zegers BJ, Rijkers GT.

J Immunol. 1991 Jun 15;146(12):4308-14.

PMID:
2040803
[PubMed - indexed for MEDLINE]
19.

Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?

Jakobsen H, Jonsdottir I.

Scand J Immunol. 2003 Aug;58(2):119-28. Review.

PMID:
12869132
[PubMed - indexed for MEDLINE]
20.

Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection.

Könen-Waisman S, Cohen A, Fridkin M, Cohen IR.

J Infect Dis. 1999 Feb;179(2):403-13.

PMID:
9878025
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk